Frank D. Yocca

2.9k total citations · 1 hit paper
51 papers, 2.3k citations indexed

About

Frank D. Yocca is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Social Psychology. According to data from OpenAlex, Frank D. Yocca has authored 51 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cellular and Molecular Neuroscience, 26 papers in Molecular Biology and 6 papers in Social Psychology. Recurrent topics in Frank D. Yocca's work include Neurotransmitter Receptor Influence on Behavior (26 papers), Receptor Mechanisms and Signaling (21 papers) and Neuroscience and Neuropharmacology Research (17 papers). Frank D. Yocca is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (26 papers), Receptor Mechanisms and Signaling (21 papers) and Neuroscience and Neuropharmacology Research (17 papers). Frank D. Yocca collaborates with scholars based in United States, Germany and Japan. Frank D. Yocca's co-authors include Kevin D. Burris, Tetsuro Kikuchi, Thaddeus F. Molski, Elaine Ryan, Katsura Tottori, Perry B. Molinoff, Cen Xu, Arlene S. Eison, Saul Maayani and Emanuel Meller and has published in prestigious journals such as JAMA, Journal of Neuroscience and Brain Research.

In The Last Decade

Frank D. Yocca

50 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

2002 736 citations Kevin D. Burris, Thaddeus F. Molski et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers

Frank D. Yocca

CMN

PMH

PHARM

Michael E. Newman Israel

Paul Van Gompel Belgium

R J Baldessarini United States

Alain Schotte Belgium

Tommy Lewander Sweden

Mark S. Kleven France

J. Arnt Denmark

Stevin H. Zorn United States

Yukihiro Ohno Japan

Sharon C. Cheetham United Kingdom

Michael E. Newman Israel

Frank D. Yocca

1.3k ×1.1

CMN

853 ×1.0

670 ×1.0

PMH

439 ×1.5

PHARM

236 ×0.9

Citations per year, relative to Frank D. Yocca Frank D. Yocca (= 1×) peers Michael E. Newman

Countries citing papers authored by Frank D. Yocca

Since Specialization

Citations

This map shows the geographic impact of Frank D. Yocca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank D. Yocca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank D. Yocca more than expected).

Fields of papers citing papers by Frank D. Yocca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank D. Yocca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank D. Yocca. The network helps show where Frank D. Yocca may publish in the future.

Co-authorship network of co-authors of Frank D. Yocca

This figure shows the co-authorship network connecting the top 25 collaborators of Frank D. Yocca. A scholar is included among the top collaborators of Frank D. Yocca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank D. Yocca. Frank D. Yocca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yocca, Frank D., et al.. (2025). Dexmedetomidine potently and reversibly regulates stress-mediated behaviors. Frontiers in Pharmacology. 16. 1589075–1589075.

Citrome, Leslie, Sheldon Preskorn, John Lauriello, et al.. (2022). Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder. The Journal of Clinical Psychiatry. 83(6). 17 indexed citations

Wong, Erik H.F., Frank D. Yocca, Mark A. Smith, & Chi‐Ming Lee. (2010). Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective. The International Journal of Neuropsychopharmacology. 13(9). 1269–1284. 74 indexed citations

Wong, Harvey, Randy Dockens, Suresh Yeola, et al.. (2007). 6-Hydroxybuspirone Is a Major Active Metabolite of Buspirone: Assessment of Pharmacokinetics and 5-Hydroxytryptamine1A Receptor Occupancy in Rats. Drug Metabolism and Disposition. 35(8). 1387–1392. 27 indexed citations

Stark, Arlene, Shaun Jordan, Kelly A. Allers, et al.. (2006). Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors: functional receptor-binding and in vivo electrophysiological studies. Psychopharmacology. 190(3). 373–382. 119 indexed citations

Mattson, Ronald J., John D. Catt, C.P. Sloan, et al.. (2003). Indanyl piperazines as melatonergic MT2 selective agents. Bioorganic & Medicinal Chemistry Letters. 13(6). 1199–1202. 26 indexed citations

Mattson, Ronald J., John D. Catt, C.P. Sloan, et al.. (2003). Development of a presynaptic 5-HT1A antagonist. Bioorganic & Medicinal Chemistry Letters. 13(2). 285–288. 11 indexed citations

Saxena, Pramod R., Peter de Vries, Jan P.C. Heiligers, et al.. (1998). BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential. European Journal of Pharmacology. 351(3). 329–339. 9 indexed citations

Saxena, P. R., Peter de Vries, Weili Wang, et al.. (1997). Effects of avitriptan, a new 5-HT1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential. Naunyn-Schmiedeberg s Archives of Pharmacology. 355(2). 295–302. 27 indexed citations

10.

Yocca, Frank D., et al.. (1996). 5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus. European Journal of Pharmacology. 317(1). 49–54. 9 indexed citations

11.

Parker, Eric M., et al.. (1994). Characterization of human 5-HT1 receptors expressed in Sf9 insect cells. European Journal of Pharmacology Molecular Pharmacology. 268(1). 43–53. 26 indexed citations

12.

Wisden, William, Eric M. Parker, Cathy D. Mahle, et al.. (1993). Cloning and characterization of the rat 5‐HT_5Breceptor. FEBS Letters. 333(1-2). 25–31. 53 indexed citations

13.

Bohmaker, Karen, et al.. (1993). Comparative effects of chronic 8-OH-DPAT, gepirone and ipsapirone treatment on the sensitivity of somatodendritic 5-HT1A autoreceptors. Neuropharmacology. 32(6). 527–534. 45 indexed citations

14.

Mahle, C.D., et al.. (1992). Allosteric interactions between the binding sites of receptor agonists and guanine nucleotides: a comparative study of the 5-hydroxytryptamine1A and adenosine A1 receptor systems in rat hippocampal membranes.. Journal of Pharmacology and Experimental Therapeutics. 263(3). 1275–1284. 10 indexed citations

15.

Yevich, Joseph P., James S. New, Duncan P. Taylor, et al.. (1992). Synthesis and biological characterization of .alpha.-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol and analogs as potential atypical antipsychotic agents. Journal of Medicinal Chemistry. 35(24). 4516–4525. 26 indexed citations

16.

Yocca, Frank D., et al.. (1990). 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats. Pharmacology Biochemistry and Behavior. 35(1). 251–254. 51 indexed citations

17.

Eison, Arlene S., Michael S. Eison, Frank D. Yocca, & Gerald Gianutsos. (1989). Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation. Life Sciences. 44(19). 1419–1427. 38 indexed citations

18.

Yocca, Frank D., Deborah K. Hyslop, Duncan P. Taylor, & Saul Maayani. (1986). Buspirone and gepirone: partial agonists at the 5HT/sub 1/A receptor linked to adenylate cyclase (AC) in rat and guinea pig hippocampal preparations. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 6 indexed citations

19.

Friedman, Eitan, Frank D. Yocca, & T B Cooper. (1984). Antidepressant drugs with varying pharmacological profiles alter rat pineal beta adrenergic-mediated function.. Journal of Pharmacology and Experimental Therapeutics. 228(3). 545–550. 26 indexed citations

20.

Friedman, Eitan & Frank D. Yocca. (1981). The effect of chronic lithium treatment on rat pineal N-acetyltransferase rhythm.. Journal of Pharmacology and Experimental Therapeutics. 219(1). 121–124. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact